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An outbreak of Streptococcus suis serotype 2
emerged in the summer of 2005 in Sichuan Province, and
sporadic infections occurred in 4 additional provinces of
China. In total, 99 S. suis strains were isolated and ana-
lyzed in this study: 88 isolates from human patients and 11
from diseased pigs. We defined 98 of 99 isolates as pulse
type I by using pulsed-field gel electrophoresis analysis of
SmaI-digested chromosomal DNA. Furthermore, multilocus
sequence typing classified 97 of 98 members of the pulse
type I in the same sequence type (ST), ST-7. Isolates of
ST-7 were more toxic to peripheral blood mononuclear cells
than ST-1 strains. S. suis ST-7, the causative agent, was a
single-locus variant of ST-1 with increased virulence.
These findings strongly suggest that ST-7 is an emerging,
highly virulent S. suis clone that caused the largest S. suis
outbreak ever described.
S
treptococcus suis, a swine pathogen, is increasing in
clinical importance in countries with intensive swine
industries (1–4). Infection in humans is considered an
occupational disease that affects persons who work in
close contact with pigs or pork byproducts (5). Currently,
35 capsular types or serotypes are officially described; S.
suis serotype 2 is considered the most prevalent and viru-
lent in pigs and humans (6). The first human case was
recorded in 1968, and only 200 cases have been subse-
quently reported globally through June 2005 (5). In some
Asian countries, S. suis may be the second most common
cause of adult streptococcal meningitis (7).
However, a larger outbreak due to S. suis serotype 2
emerged in the summer of 2005 in Sichuan Province,
China. In total, 215 cases were reported; 38 deaths occurred
in 202 villages in 36 counties. New cases were identified in
4 additional provinces in China after the Sichuan outbreak.
A striking feature of this outbreak was the unusually high
rate of death and streptococcal toxic shocklike syndrome
(STSS) as a clinical manifestation. Indeed, reported symp-
toms included high fever, malaise, nausea, vomiting, and
diarrhea, followed by meningitis, subcutaneous hemor-
rhage, toxic shock, and coma in severe cases. This
increased severity of S. suis infections in humans, such as
the shorter incubation time, more rapid disease progression,
and higher death rate, underscores the need to better under-
stand the factors associated with S. suis infection.
The aim of this study was to characterize and analyze
the causative agent of this unusual outbreak with regard to
its virulence and evolution. Using multilocus sequence
typing (MLST), we classified the isolated strains into a
single sequence type (ST), ST-7 of the ST-1 complex. The
ST-1 complex is strongly associated with cases of sep-
ticemia and meningitis worldwide (8).  S. suis ST-7
expressed the proposed virulence markers muramidase-
released protein (MRP), extracellular protein factor (EF),
and hemolysin (named suilysin) (9–11) and was markedly
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Methods
Bacterial Isolation and Identification
All α-hemolytic streptococcal colonies grown on sheep
blood agar from specimens obtained from normally sterile
sites on humans or diseased pigs were identified as S. suis
by API-20 STREP system (Biomerieux, WeTech, Beijing,
People’s Republic of China) (Table). The specific serotype
of the isolates was characterized as S. suis capsular type 2
by using S. suis antisera specific against individual
serotypes (provided by the Statens Serum Institut,
Copenhagen, Denmark) and confirmed by the coagglutina-
tion test, as previously reported (12). PCR assays were used
to detect the genes coding for 16S rRNA of S. suis, for the
capsule of S. suis serotype 2 (cps2J), and for MRP, suilysin
(sly), and EF, as reported (9,10,13). PCR results were con-
firmed by sequencing the synthesized fragments. The
expression of the virulence markers MRP, suilysin, and EF
was confirmed at the protein level by Western blotting bac-
terial culture supernatants as previously described (11).
Pulsed-field Gel Electrophoresis (PFGE) Analysis
The protocol described by Berthelot-Hérault et al., with
modification, was used (14). Cells were restricted with 25
U of SmaI (Promega, Sino-American Biotechnology Co,
Beijing, People’s Republic of China). DNA fragments
were resolved by PFGE with 1% SeaKem Gold agarose
gels and the CHEF-DR III system (Bio-Rad, Beijing,
People’s Republic of China). Salmonella enterica serovar
Braenderup H9812 restricted with XbaI was used for
molecular weight and size determinations (15).
Similarities between restriction endonuclease digestion
profiles were analyzed by using BioNumerics software
(Applied Maths, Kortrijk, Belgium).
MLST and Phylogenetic Analysis
Seven housekeeping gene loci described by King et al.
for MLST analysis of S. suis were used in this study:
cpn60, dpr, recA, aroA, thrA, gki, and mutS coding for a
60-kDa chaperonin, a putative peroxide resistance protein,
a homologous recombination factor, a 5-enolpyruvylshiki-
mate 3-phosphate synthase, an aspartokinase/homoserine
dehydrogenase, a glucose kinase, and a DNA mismatch
repair enzyme, respectively (8). PCR products were puri-
fied by using QIAquick PCR product purification columns
(Qiagen, Gene, Beijing, People’s Republic of China) and
directly sequenced at both ends with an ABI Prism 3700
DNA analyzer system (Perkin Elmer Applied Biosystems,
Wellesley, MA, USA) (8). For each isolate, the alleles at
each of the 7 loci defined the allelic profile or ST. MLST
information in the S. suis database identified the phyloge-
netic position of isolates collected in this outbreak investi-
gation (8). eBURST was used to identify clonal complexes
within S. suis and to display the overall structure of the
population in the MLST database at http://ssuis.mlst.net
(16,17). This database contains 92 previously described
STs derived from isolates from various sources, including
diseased pigs and human patients from different countries.
Bayesian maximum likelihood trees were reconstructed
with MrBayes version 3.1.1, and maximum likelihood
trees were made with the HKY85 model (18).
Cytotoxicity Assays
Bacterial cytotoxicity to PBMCs from healthy donors
was determined as previously described (19). PBMCs
were seeded at a final concentration of 106 cells/mL in 24-
well plates and incubated for 4 h at 37°C in the presence of
≈107 CFU/mL S. suis strain SC84 and SC22 (selected as 2
representative strains from the Sichuan outbreak and iso-
lated from 2 human patients with STSS) or S. suis refer-
ence strain 31533 used as a control. Strain 31533, isolated
from a pig with meningitis in France, was virulent in pig
models of infection and toxic to several types of host cells
(19,20). Bacterial cytotoxicity was evaluated by lactate
dehydrogenase measurement with Cyto-Tox 96 Cytoxicity
Kit (Promega, Madison, WI, USA) according to the man-
ufacturer’s instructions. Percentage of cytotoxicity was
calculated as (sample optical density [OD]490 –
OD0%)/(OD100% – OD0%)×100, where OD0% represents the
OD490 of noninfected cells and OD100% represents the
OD490 of cells treated with lysis buffer as indicated by the
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Results
In total, 99 S. suis strains were isolated in this study
(Table): 88 from human patients and 11 from diseased
pigs. Of the 88 human isolates, 1 each was from
Guangdong, Jiangxi, Guizhou, and Guangxi. From the
Sichuan outbreak in the summer of 2005, we found 84
human isolates, distributed in 63 administrative villages of
29 counties, and included them in this study. Two strains,
1 from a human patient and 1 from a diseased pig in
Jiangsu during the 1998 S. suis outbreak, were also includ-
ed to determine whether the causative agents for the 2 out-
breaks were clonal (21).
Of the 11 pig isolates obtained in 2005, 8 were from
Sichuan and 3 were from Jiangxi. One of the 8 isolates
from Sichuan, named SC16, originated from 1 diseased pig
in a herd. The human patient, who slaughtered and
processed the first diseased pig in the same herd, became
ill 6 hours later and died 18 hours after the onset of illness.
The 3 isolates from Jiangxi were isolated from infected
meat samples from a cold storage house. The human
patient who processed the meat was infected.
All strains were determined as serotype 2 by using
diagnostic antiserum against S. suis and confirmed by the
coagglutination method with specific type 2 antiserum
(12). The identity of the isolates as S. suis serotype 2 was
further confirmed by positive PCR for the genes coding for
the 16S rRNA of S. suis and for the capsule of S. suis
serotype 2 (cps2J).
PCR showed all isolates to be positive for the virulence
genes coding for MRP, suilysin (sly), and EF (9,10). PCR
results were confirmed with nucleotide sequencing. Ten
selected strains tested positive for suilysin, EF, and MRP
by Western blot with specific antibodies, as described pre-
viously, which confirmed the expression of these viru-
lence-related genes (11). We saw no indication that S. suis
was transmitted between humans, and almost all patients
had contact with pigs or infected meat (22).
PFGE effectively detected relationships between genet-
ic background, virulence traits, and epidemiologic impli-
cations of many bacterial pathogens. Vela et al. analyzed
302 S. suis clinical isolates of various serotypes from var-
ious countries and identified 60 different pulse types, of
which 50% corresponded to a single pulse type. One pulse
type represented 46.3% of the swine isolates that may be
related to a higher pathogenic potential or to a wider envi-
ronmental distribution (23). In this study, chromosomal
DNA digested with SmaI was analyzed in the 101 isolates
described in the Table. Results showed 2 pulse types. Pulse
type I was found in 100 of the 101 isolates, including those
from human patients and diseased pigs from Sichuan and
4 other provinces: Jiangxi, Guangdong, Guangxi, and
Jiangsu (Figure 1). This finding indicates that pulse type I
was the primary cause of this human outbreak and that the
causative agent was clonal. Only 1 isolate, GZ1, isolated in
August 2005 and having a slightly different PFGE profile,
was from a human patient in Guizhou Province (Figure 1).
Although the PFGE-based network, PulseNet
International, is used worldwide for molecular epidemiol-
ogy, no database is available for S. suis to enable compar-
ison of genetic relatedness among isolates from various
origins. MLST defines strains by using sequences at 7
housekeeping loci and has become the method of choice
for addressing questions related to epidemiology, popula-
tion, and evolutionary biology. The MLST network,
http://www.mlst.net, allows laboratories to quickly char-
acterize their strains, relate them to those submitted by
others, and compare them with the pathogen populations
as a whole through the Internet (16,24). The selected 7
housekeeping gene loci from all 101 S. suis isolates were
amplified and sequenced. DNA sequences from the 7 loci
of all isolates were determined (DQ205243-51), and allel-
ic profiles were assigned and submitted to the MLST data-
base for S. suis (http://ssuis.mlst.net) (8). In our study, 99
of 101 isolates were identified as ST-7, including all 92
isolates from human patients and diseased pigs collected
during the Sichuan outbreak in 2005, as well as the 2 iso-
lates from the Jiangsu outbreak in 1998 (1 from a human
patient and 1 from a diseased pig). In addition, the isolates
from Jiangxi (1 human and 3 pig isolates) and Guangdong
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Figure 1. Pulsed-field gel electrophoresis (PFGE) profiles of
selected isolates from various parts of China. All isolates of
Streptococcus suis were digested with SmaI. The molecular size
of each restriction fragment was calculated with the Comparative
Quantification/Polymorphism analysis feature of the Molecular
Analyst Fingerprinting Plus software (Quantity One version 4.0,
Bio-Rad, Beijing, People’s Republic of China) based on mobility of
S. suis isolates on the same gel with Salmonella enterica serovar
Braenderup H9812 digested with XbaI, as universal standard of
PulseNet International. Clustering of PFGE patterns was per-
formed by an unweighted paired group with arithmetic averaging
(UPGMA). The dendrogram of PFGE patterns of isolates tested
were drawn with PulseNet software BioNumerics, with a 1.5%
position tolerance and 1% optimization.(1 human isolate) obtained during summer 2005 were also
assigned to ST-7. One human isolate from a patient in
Guizhou (strain GZ1) and 1 human isolate from Guangxi
(strain GX1) were identified as ST1 (DQ205251). Strain
GZ1 showed a PFGE profile that differed slightly from
that of the Sichuan isolates (Figure 1, pulse type II).
However, strain GX1 had a pulse type I profile similar to
that of the Sichuan isolates. These results indicate that
MLST is a more powerful discriminatory and epidemio-
logic tool.
To gain information on the origin and relationships
between ST-7 and other STs, we evaluated the population
genetic diversity of the entire S. suis MSLT database with
eBURST, which divides an MLST dataset of any size into
groups of related isolates and clonal complexes, predicts
the ancestral genotype for each clonal complex, and com-
putes the bootstrap relatedness value. Using this technique,
we showed bacterial clonal diversity in S. suis and provid-
ed evidence for the emergence of new clones of particular
clinical relevance (17). The population snapshot of all iso-
lates of S. suis generated by eBURST, including our 101
isolates along with all 294 isolates with available MLST
data, showed 6 major clusters of related STs and numerous
unlinked STs. Of unlinked STs, we noted 6 ST complexes
with single-locus variants and some with double-locus
variants (8,17). Interspersed among these clonal complex-
es were minor groups, typically joined doublets and indi-
vidually unlinked STs that were not single-locus variants
of any other STs in the database (Figure 2).
The 6 major clonal complexes with single- and double-
locus variants were ST-1, ST-17, ST-27, ST-61, ST-29, and
ST-87 (Figure 2). The major clonal complex of S. suis, ST-
1, contained isolates from humans and pigs that had inva-
sive disease or were healthy carriers and included, besides
serotype 2, isolates of serotypes 1, 1/2, 3, 8, 14, and 1/14.
ST-1, original strain of the ST-1 complex (with 100% boot-
strap support), includes pig isolates from England (83),
Spain (44), the Netherlands (3), France (4), and Hong
Kong (5); it is the predominant ST responsible for most
swine infections worldwide.
ST-7 may be derived from ST-1, the primary strain of
the clonal ST-1 complex, and it may have caused the
human infections in Sichuan Province. ST-7 (ST profile
1,1,1,1,1,1,3) (DQ205243-50) and ST-1 (ST profile
1,1,1,1,1,1,1) (DQ205243-51) may have diversified by a
stepwise accumulation of point mutations. Furthermore,
ST-7 may have only very recently diverged, since it
showed a high level of similarity in terms of both allelic
profiles and sequences to their nonidentical alleles. Thus,
the closely related ST-1 and ST-7 share 6 identical loci
and have 1 locus, thyA, differing only at a single
nucleotide (Figure 2). Because the housekeeping genes
are recognized as the stable core of the bacterial genome,
this divergence further shows the emergence of a new
virulent ST.
Using eBURST analysis of the MSLT database, we also
examined isolates of S. suis serotype 2 from human
patients or diseased pigs that have been shown experimen-
tally to be highly virulent in porcine models of infection
(8,20,25). Six of the 7 so-called highly virulent strains
belonged to ST-1, including 1 strain isolated from a patient
with meningitis in England (H11/1) and 1 strain isolated
from an abattoir worker with meningitis in Hong Kong
(87555). Another highly virulent strain (89-1591) isolated
from a pig with septicemia was ST-25, a single-locus vari-
ant of the ST-29 complex (26).
Discussion
Strains isolated from human patients (including those
from the MLST database and this study) can be regrouped
in either ST-1, ST-6, ST-7, and ST-84 (ST-1 complex) or
ST-25 (ST-29 complex) by MLST. ST-1 includes 10 iso-
lates of S. suis serotype 2 recovered from human infections
in France (n = 4), England (n = 1), and Hong Kong. The
Hong Kong strains were isolated in 1985 (n = 1), 1995 (n
= 3), and 1997 (n = 1). In addition, ST-1 also includes 1
strain of S. suis serotype 14 isolated from a patient in
England. ST-25 contains the only 3 serotype 2 strains iso-
lated from human patients in Canada (27,28). ST-6 con-
tains a strain of serotype 14 isolated from a human patient
in the Netherlands (29). Before our study, only 1 member
of ST-7 had been isolated from the blood of a patient with
sepsis in Hong Kong in 1996 (8,30). The ST-1 and ST-29
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Figure 2. Population snapshot of Streptococcus suis. The entire S.
suis multilocus sequence type database is displayed as a single
eBURST diagram. The 6 major sequence type (ST) complexes are
each denoted by a number. The patterns of descent within these
ST complexes are discussed in the text. Primary founders (dark
green) are positioned centrally in the cluster, and subgroup
founders are shown in light green, except ST-7, which is shown in
orange to emphasize its importance. The area of each circle in the
diagram corresponds to the abundance of the isolates of the ST in
the input data.complexes are highly virulent clones of S. suis popula-
tions, and the ST-1 clonal complex is the major complex of
S. suis with public health ramifications and is responsible
for most human infections. The 3 isolates in ST-25 have
none of the recognized virulence genes in S. suis: ef, mrp,
and sly. Therefore, we propose that the ST-1 clonal com-
plex is the dominant highly virulent complex and has the
potential to cause large human S. suis infection outbreaks.
The potential of ST-7 as an emerging virulent clone within
the ST-1 complex was further suggested by results
obtained by using the cytotoxicity assay with human
PBMCs. As shown in Figure 3, live bacterial cell suspen-
sions prepared from S. suis strains SC84 and SC22 (ST-7),
isolated from human patients with STSS in Sichuan, were
significantly more toxic to PBMCs than the S. suis refer-
ence strain 31533 (ST-1) when cells were incubated >2
hours under similar conditions of bacterial growth. Strain
31533 was virulent in mouse and pig models of infection
and was toxic to several types of host cells, as demonstrat-
ed by in vitro assays (19). Thus, this difference in cytotox-
icity is not only significant but also relevant to the
fulminant characteristics of the Sichuan outbreak.
This hypothesis is further supported by phylogenetic
analysis of the sequences from 92 STs of the 7 S. suis
housekeeping genes (Figure 4). To show the phylogenetic
relationships between the ST-1 complex and genetic popu-
lations of S. suis, we examined the possibility that phylo-
genetic data were sufficient to construct a relatedness tree
among members of STs and, in particular, for the virulent
clonal ST-1 complex. Phylogenetic analysis showed 6
lineages within the S. suis population. The previously iden-
tified complexes ST-61, ST-27, and ST-87 were placed in
lineages 2, 5, and 6, respectively; most of the STs have
only a single isolate. The ST-29 complex that contains
human isolates of ST-25 is in lineage 5. The clonal ST-1
complex forms a single lineage and appears to be dominant
in various locations (8). It has 4 STs for human isolates,
ST-1, ST-6, ST-7, and ST-84, which may have evolved
from a common ancestor (Figure 4). In this complex, S.
suis ST-7 emerged first in Hong Kong in 1996, caused 28
cases in Jiangsu Province in 1998, and was responsible for
the largest outbreak of human S. suis infection in history
that occurred in Sichuan Province, China, in 2005 and
resulted in 215 cases with 38 deaths (8,21,30).
The high death rate in the Sichuan outbreak is of great
concern since few human S. suis infections are fatal. This
increased virulence may be related to a horizontal gene
transfer of a possible new toxin or superantigen consistent
with the most relevant clinical manifestation of this out-
break, i.e., STSS. Recently, resistance gene exchanges were
reported between porcine S. suis and various human strep-
tococcal species, including S. pyogenes. Thus, gene transfer
Streptococcus suis Sequence Type 7 Outbreak
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Figure 3. Cytotoxicity of Streptococcus suis sequence type (ST) 7
to human peripheral blood mononuclear cells. Data were collected
from 3 experiments, which were performed in triplicate and
expressed as the mean percentage of cytotoxicity, plus or minus
standard deviations. *p<0.001 (compared to the value of S. suis
ST-1 representative strain 31533) as determined by analysis of
variance with SAS version 8 software (SAS Institute, Cary, NC,
USA).
Figure 4. Unrooted Bayesian tree of the concatenated sequence
of the 92 sequence types (STs) of Streptococcus suis. The tree
was constructed by using MrBayes (version 3.1.1) according to the
HKY85 model of DNA substitution with no rate variation across
sites. Four Markov chains were run for a million generations, and
the Markov chain is sampled every 100 generations (18). The
sampled parameter values were summarized by discarding the
first 2,000 samples as burn-in. On the basis of the last 9,000 sam-
ples taken from the posterior probability distribution, a 50% major-
ity rule consensus tree was computed. The posterior probability
given on each branch is a percentage of these trees supporting
each node. The 6 lineages defined in this study are shadowed in
light gray. The 6 major clonal complexes identified previously by
King et al. (8) as well as in this study are shadowed in dark gray.
The five STs containing isolates from human invasive disease are
shown as red dots. Alarger version of this figure is available online
at http://www.cdc.gov/ncidod/EID/vol12no08/06-0232-G4.htmfrom porcine to human streptococci and vice versa is
possible, albeit at a low frequency (31). Therefore, S. suis
ST-7 might be an emerging virulent infectious disease. This
unusual S. suis clone may spread further across China and
to the rest of the world; spread may become more pro-
nounced with the rapid development of the export business.
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